Target intelligence / Profile preview

Cold pathogen

Molecular classification
Pathogen category, Viral group, Not a specific molecule
01

Overview

The term "Cold pathogen" does not refer to a specific molecular target or receptor but is a collective term used to describe the diverse group of infectious agents responsible for the common cold and related upper respiratory tract infections. In clinical and traditional medicine contexts, it often refers to environmental stressors or pathogenic influences, such as the "Han Xie" described in Traditional Chinese Medicine. Biologically, this category encompasses over 200 viral strains, most prominently Human Rhinoviruses (HRVs), Coronaviruses, and Respiratory Syncytial Virus (RSV). These pathogens initiate infection by binding to host cell receptors like ICAM-1, LDLR, or CDHR3 and hijacking cellular processes for replication and capsid assembly. Modern therapeutic research focuses on specific molecular targets within this category, such as the viral 3C protease or host enzymes like N-myristoyltransferase (NMT) which are essential for viral proliferation. Because of the vast genomic diversity and rapid evolution of these viruses, no single therapeutic agent currently exists that targets all "cold pathogens" as a unified entity.

Other names
Common cold pathogenExternal cold pathogenHan XieCold evilUpper respiratory tract infection pathogens
02

Mechanism of action

Drugs associated with this category typically function by inhibiting specific viral enzymes (e.g., protease inhibitors like Rupintrivir), blocking viral capsid attachment (e.g., Pleconaril), or inhibiting host enzymes required for viral assembly (e.g., NMT inhibitors like IMP-1088).

03

Biological functions

Viral infectionHost cell hijackingViral replicationInflammatory response induction
04

Disease associations

InfectionCommon coldUpper respiratory tract infectionAsthma exacerbationCOPD exacerbation
05

Safety considerations

Viral resistanceHigh serotype diversity (over 200 strains)Potential host-cell toxicity for host-directed therapiesRapid viral evolution
06

Interacting drugs

Rupintrivir

4 more in the full profile.

07

Biomarkers

Viral loadNasal proinflammatory cytokines (IL-6, IL-8, CXCL10)Interferon-alphaNeutrophil counts in nasal secretions

Beyond the preview

Go deeper on Cold pathogen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cold pathogen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call